Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Holdings
Ownership


All
13F
13D/G
Other
Tags
CC transcript
NOVARTIS AG (NVS) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/04/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K"
10/02/2023 6-K Quarterly results
08/21/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K"
08/09/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K"
07/18/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"99.1 FINANCIAL REPORT Q2 2023"
07/10/2023 DFAN14A Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
07/10/2023 6-K Quarterly results
06/12/2023 DFAN14A Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
06/12/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K"
05/31/2023 SD Form SD - Specialized disclosure report:
05/15/2023 20-F/A Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
04/25/2023 6-K Quarterly results
03/27/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K"
03/24/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
02/01/2023 6-K Quarterly results
02/01/2023 6-K Quarterly results
02/01/2023 IRANNOTICE Form IRANNOTICE - Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)).:
02/01/2023 20-F Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
01/10/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/16/2022 F-6 POS Form F-6 POS - Post-effective amendments for immediately effective filing:
12/05/2022 6-K Quarterly results
10/25/2022 6-K Quarterly results
10/24/2022 6-K Quarterly results
09/21/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K"
08/25/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K"
07/19/2022 6-K Quarterly results
06/27/2022 3 NOVARTIS PHARMA AG (10% Owner) has filed a Form 3 on PRECISION BIOSCIENCES INC
06/21/2022 6-K Quarterly results
05/31/2022 SD Form SD - Specialized disclosure report:
04/26/2022 20-F/A Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
04/26/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"99.1 FINANCIAL REPORT Q1 2022",
"99.2 INTERIM FINANCIAL REPORT"
04/04/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K"
02/04/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/02/2022 IRANNOTICE Form IRANNOTICE - Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)).:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy